BioSpace News Archive

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced its financial results for the second quarter of 2022 and provided a business and clinical update.

Halozyme Therapeutics, Inc. today announced that it intends to offer, subject to market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2028 (the “Convertible Notes”).

Acurx Pharmaceuticals, Inc. announced today certain financial and operational results for the quarter ended June 30 , 2022.

Gelesis (NYSE: GLS), the maker of Plenity for weight management, today reported financial results for the second quarter of 2022.

9 Meters Biopharma, Inc. today provided an overview of its recent achievements, important upcoming milestones, and financial results for the second quarter ended June 30, 2022.

UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), today announced the sale of $67.5 million in aggregate principal amount of a new series of variable rate convertible senior secured notes due December 15, 2025 (the “2025 Notes”) in a private placement transaction, raising approximately $22.5 million in gross cash proceeds after paying for a repurchase of $45.0 million of its 6.25% convertible senior notes due 2026.

Ainos, Inc. today announced its unaudited financial results for the second quarter ended June 30, 2022.

Miravo Healthcare ™ Announces Second Quarter 2022 Results.

Columbia Care Inc. today reported financial and operating results for the second quarter ended June 30, 2022.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced the appointments of Rahul Ballal, Ph.D., chief executive officer of Imara, and Cynthia Smith, former chief commercial officer of ZS Pharma, to its board of directors.